SwissHealth Ventures: digital, innovative, personal.
SwissHealth Ventures invests in start-ups whose ideas set the course for a high quality, cost-effective healthcare system.Our focus
SwissHealth Ventures AG is a member of the CSS Group, Switzerland's leading health insurer. We are the ideal healthcare partner for ambitious start-ups in the field of digital health.
Our industry-specific expertise is complemented by the support of experienced venture capital partner Redstone, enabling agile and sustainable growth.
We invest in start-ups that advance healthcare with new digital technologies and strive for synergies with the CSS Group. With targeted investments, we want to support people in staying healthy, getting healthy, or living with an illness. In addition, we focus on digital solutions that directly increase efficiency for the core business of health insurers.
More efficient thanks to new technologies
Lifestyle and wellness innovations
Digitally assisted recovery
Support for chronic illnesses
Does your start-up fit our investment criteria and are there potential synergies with the CSS Group? Then we look forward to hearing from you.
With OnlineDoctor, skin problems can be assessed quickly, regardless of location and at low cost by dermatologists licensed in Switzerland. Via a web-based platform, patients receive an initial specialist assessment including a recommendation for action within 48 hours. SwissHealth Ventures participated in 2020 as lead investor in this Swiss telemedicine start-up as part of the A-round (investment volume of all investors total around 5.5 million Swiss francs).
CSS has already made this service a fixed part of its offering, where it is known as the «online skin check». The uncomplicated skin check by Swiss dermatologists contributes to digital integrated care.
Pregnolia has developed a device that supports the diagnosis of premature birth. It enables gynaecologists to measure cervical stiffness more precisely and thus make a better assessment of the risk of premature birth. SwissHealth Ventures invested in this ETH spin-off in 2020 in the series A round (which raised a total of 4.2 million Swiss francs in funding from all investors).
SwissHealth Ventures believes in the success of the Pregnolia measurement system and its ability to provide great reassurance to professionals and pregnant women. In addition, we believe that this method will reduce healthcare costs in the long term.